SI20076A
(sl)
*
|
1996-10-16 |
2000-04-30 |
Icn Pharmaceuticals, Inc. |
Monociklični L-nukleozidi, analogi in uporaba od teh
|
JP2002501546A
(ja)
*
|
1997-06-30 |
2002-01-15 |
アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド |
チアゾフリンおよびその他のc−ヌクレオシドを作製する方法
|
JP4596495B2
(ja)
*
|
1997-07-18 |
2010-12-08 |
ソニー株式会社 |
制御装置、制御方法、電気機器システム、電気機器システムの制御方法、および、記録媒体
|
US7901400B2
(en)
|
1998-10-23 |
2011-03-08 |
Covidien Ag |
Method and system for controlling output of RF medical generator
|
AU774720B2
(en)
|
1998-11-05 |
2004-07-08 |
Centre National De La Recherche Scientifique |
Nucleosides with anti-hepatitis B virus activity
|
DE69930678T2
(de)
*
|
1998-11-05 |
2006-09-21 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Azidoderrivate von Beta-L-2'-Nukleosiden zur HIV-Infektionsbehandlung
|
US6407077B1
(en)
|
1998-11-05 |
2002-06-18 |
Emory University |
β-L nucleosides for the treatment of HIV infection
|
EP1146883A4
(fr)
*
|
1999-01-29 |
2004-11-24 |
Icn Pharmaceuticals |
Modulation de reponse immunitaire par la ribavirine
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
US7053207B2
(en)
|
1999-05-04 |
2006-05-30 |
Exiqon A/S |
L-ribo-LNA analogues
|
US6525191B1
(en)
*
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
AU7019200A
(en)
*
|
1999-08-31 |
2001-03-26 |
Nycomed Amersham Plc |
Nucleoside analogues
|
US6664399B1
(en)
*
|
1999-09-02 |
2003-12-16 |
E. I. Du Pont De Nemours & Company |
Triazole linked carbohydrates
|
US6518253B1
(en)
*
|
1999-11-19 |
2003-02-11 |
Robert Tam |
Treatment of viral infections using the L-isomer of ribavirin
|
CA2384326A1
(fr)
*
|
1999-12-23 |
2001-06-28 |
Johnson Lau |
Compositions et procedes relatives a des nucleosides-l, a des nucleotides-l ainsi qu'a leurs analogues
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
US6455508B1
(en)
*
|
2000-02-15 |
2002-09-24 |
Kanda S. Ramasamy |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
|
KR20100003313A
(ko)
*
|
2000-04-13 |
2010-01-07 |
파마셋 인코포레이티드 |
간염 바이러스 감염 치료를 위한 3'- 또는 2'-하이드록시메틸 치환된 뉴클레오시드 유도체
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EP1736478B1
(fr)
*
|
2000-05-26 |
2015-07-22 |
IDENIX Pharmaceuticals, Inc. |
Procédés et compositions de traitement des flavivirus et des pestivirus
|
US6815542B2
(en)
*
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
US6680059B2
(en)
*
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US6858590B2
(en)
*
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
*
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
ATE517184T1
(de)
|
2000-08-17 |
2011-08-15 |
Tripep Ab |
Hcv ns3/4a kodierende nukleinsäure
|
US6720000B2
(en)
*
|
2001-03-19 |
2004-04-13 |
Three Rivers Pharmaceutical, Llc |
Process for producing wet ribavirin pellets
|
DE60101056T2
(de)
*
|
2001-07-30 |
2004-05-19 |
Clariant Life Science Molecules (Italia) S.P.A., Origgio |
Verfahren zur Herstellung von Ribavirin
|
EP1435974A4
(fr)
*
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
Procedes et compositions pour le traitement du virus de l'hepatite c au moyen de nucleosides modifies en 4'
|
CA2465159A1
(fr)
*
|
2001-11-02 |
2003-05-15 |
Sandoz Inc. |
Procede de preparation de compositions de ribavirine a charge elevee et a dissolution rapide
|
KR100411398B1
(ko)
*
|
2001-12-06 |
2003-12-18 |
주식회사유한양행 |
베타-디-리보푸라노즈 유도체의 제조방법
|
AU2003213628A1
(en)
*
|
2002-02-28 |
2003-09-16 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
US7749217B2
(en)
|
2002-05-06 |
2010-07-06 |
Covidien Ag |
Method and system for optically detecting blood and controlling a generator during electrosurgery
|
US6982253B2
(en)
|
2002-06-05 |
2006-01-03 |
Supergen, Inc. |
Liquid formulation of decitabine and use of the same
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
NZ537662A
(en)
*
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
BR0312278A
(pt)
*
|
2002-06-28 |
2007-06-19 |
Idenix Cayman Ltd |
éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
|
MXPA05001298A
(es)
*
|
2002-08-01 |
2005-11-04 |
Pharmasset Inc |
Compuestos con el sistema biciclo[4.2.1] nonano para el tratamiento de infecciones por flaviviridae.
|
DE60304484T2
(de)
*
|
2002-08-12 |
2006-11-09 |
F. Hoffmann-La Roche Ag |
Verfahren zur herstellung von einem ribofuranose
|
US7538094B2
(en)
*
|
2002-09-19 |
2009-05-26 |
Three Rivers Pharmacueticals, Llc |
Composition containing ribavirin and use thereof
|
US20040077607A1
(en)
*
|
2002-10-21 |
2004-04-22 |
Uckun Fatih M. |
Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
|
EP2241325B1
(fr)
|
2002-10-29 |
2012-02-08 |
Coley Pharmaceutical Group, Inc. |
Utilisation des oligonucleotides CPG dans le traitement de l'hépatite C
|
RU2005118421A
(ru)
*
|
2002-11-15 |
2006-01-20 |
Айденикс (Кайман) Лимитед (Ky) |
2'-разветвленные нуклеозиды и мутация flaviviridae
|
US7044948B2
(en)
|
2002-12-10 |
2006-05-16 |
Sherwood Services Ag |
Circuit for controlling arc energy from an electrosurgical generator
|
CA2509687C
(fr)
*
|
2002-12-12 |
2012-08-14 |
Idenix (Cayman) Limited |
Procede de production de nucleosides ramifies en position 2'
|
JP2006514038A
(ja)
*
|
2002-12-23 |
2006-04-27 |
イデニクス(ケイマン)リミテツド |
3’−ヌクレオシドプロドラッグの生産方法
|
US7038038B2
(en)
*
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
US6943249B2
(en)
*
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
EP1626692A4
(fr)
*
|
2003-03-28 |
2008-12-10 |
Pharmasset Inc |
Composes permettant de traiter les infections par flavivirus
|
CA2524289C
(fr)
|
2003-05-01 |
2016-01-19 |
Sherwood Services Ag |
Procede et systeme de programmation et de commande d'un generateur electrochirurgical
|
PT3521297T
(pt)
*
|
2003-05-30 |
2022-03-18 |
Gilead Pharmasset Llc |
Análogos de nucleosídeo fluorados modificados
|
US20050009848A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Icn Pharmaceuticals Switzerland Ltd. |
Use of antivirals against inflammatory bowel diseases
|
US6930093B2
(en)
*
|
2003-07-10 |
2005-08-16 |
Valeant Research & Development |
Use of ribofuranose derivatives against inflammatory bowel diseases
|
ES2351603T3
(es)
*
|
2003-07-25 |
2011-02-08 |
Idenix Pharmaceuticals, Inc. |
Análogos de nucleósidos de purina para el tratamiento de enfermedades causadas por flaviridae incluyendo hepatitis c.
|
WO2005018330A1
(fr)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Regime de dosage pour therapie contre flaviviridae
|
CA2542798C
(fr)
|
2003-10-23 |
2015-06-23 |
Sherwood Services Ag |
Circuit de mesure de thermocouple
|
AU2003284929B2
(en)
|
2003-10-23 |
2010-07-22 |
Covidien Ag |
Redundant temperature monitoring in electrosurgical systems for safety mitigation
|
US7396336B2
(en)
|
2003-10-30 |
2008-07-08 |
Sherwood Services Ag |
Switched resonant ultrasonic power amplifier system
|
US7131860B2
(en)
|
2003-11-20 |
2006-11-07 |
Sherwood Services Ag |
Connector systems for electrosurgical generator
|
US7766905B2
(en)
|
2004-02-12 |
2010-08-03 |
Covidien Ag |
Method and system for continuity testing of medical electrodes
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
US7780662B2
(en)
|
2004-03-02 |
2010-08-24 |
Covidien Ag |
Vessel sealing system using capacitive RF dielectric heating
|
AU2005256963A1
(en)
*
|
2004-06-23 |
2006-01-05 |
Centre National De La Recherche Scientifique |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
SG192409A1
(en)
|
2004-09-14 |
2013-08-30 |
Gilead Pharmasset Llc |
2-deoxy-2-fluoro-2-c-methyl-ribono lactones, and preparation thereof and 1,3-dioxolanes
|
WO2006074416A1
(fr)
*
|
2005-01-07 |
2006-07-13 |
Health Research Inc. |
5-amino-4-imidazolecarboxamide riboside et sa nucléobase en tant qu'agents amplificateurs du transport et du métabolisme d'antifolates
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
EP2805719A1
(fr)
*
|
2005-03-30 |
2014-11-26 |
Glaxosmithkline LLC |
Nicotinamide riboside et analogues
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
EP1888751A2
(fr)
*
|
2005-05-25 |
2008-02-20 |
Tripep Ab |
Gene de fusion ns3/4a non structurel de l'hepatite c
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
US8734438B2
(en)
|
2005-10-21 |
2014-05-27 |
Covidien Ag |
Circuit and method for reducing stored energy in an electrosurgical generator
|
US7947039B2
(en)
|
2005-12-12 |
2011-05-24 |
Covidien Ag |
Laparoscopic apparatus for performing electrosurgical procedures
|
US7781576B2
(en)
*
|
2005-12-23 |
2010-08-24 |
Idenix Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
US7651493B2
(en)
|
2006-03-03 |
2010-01-26 |
Covidien Ag |
System and method for controlling electrosurgical snares
|
RU2498813C2
(ru)
*
|
2006-03-09 |
2013-11-20 |
Ом Фарма |
Иммуномодуляторные соединения и лечение заболеваний, связанных со сверхпродукцией воспалительных цитокинов
|
FR2907786B1
(fr)
*
|
2006-10-27 |
2009-09-18 |
Univ Grenoble 1 |
Thionucleosides et applications pharmaceutiques
|
AU2007325551A1
(en)
*
|
2006-09-11 |
2008-06-05 |
Arrowhead Center Inc. |
Azole nucleosides and use as inhibitors of RNA and DNA varial polymerases
|
CN101595117B
(zh)
*
|
2006-12-08 |
2014-01-22 |
株式会社Api |
呋喃糖衍生物的制造方法
|
WO2008086341A1
(fr)
*
|
2007-01-09 |
2008-07-17 |
Pericor Therapeutics, Inc. |
Procédés, compositions et formulations pour prévenir ou réduire les effets indésirables chez un patient
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
EP2185195A2
(fr)
*
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Plate-forme immunogène
|
US20090214593A1
(en)
*
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
EP3025714B9
(fr)
|
2007-09-14 |
2020-11-18 |
Biogen MA Inc. |
Compositions et procédés de traitement de la leucoencéphalopathie multifocale progressive (lemp)
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
PT3782611T
(pt)
|
2008-05-15 |
2022-11-18 |
Celgene Corp |
Formulações orais de análogos da citidina e métodos de utilização dos mesmos
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
KR20110098849A
(ko)
|
2008-12-23 |
2011-09-01 |
파마셋 인코포레이티드 |
뉴클레오시드 유사체
|
AU2009329872B2
(en)
|
2008-12-23 |
2016-07-07 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
EP2623104A1
(fr)
*
|
2009-03-20 |
2013-08-07 |
Alios Biopharma, Inc. |
Analogues nucléosidiques et nucléotidiques substitués
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI576352B
(zh)
*
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
TW201139457A
(en)
|
2010-03-31 |
2011-11-16 |
Pharmasset Inc |
Stereoselective synthesis of phosphorus containing actives
|
ES2701020T3
(es)
|
2010-09-22 |
2019-02-20 |
Alios Biopharma Inc |
Nucleósidos azido y análogos nucleotídicos
|
CA2810928A1
(fr)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Analogues nucleotidiques substitues
|
CA2818853A1
(fr)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides destines a la therapie contre le virus de l'hepatite c et le virus de la dengue
|
GB201021867D0
(en)
*
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
Non-coding immunomodulatory DNA construct
|
CN102153548B
(zh)
*
|
2011-02-24 |
2012-11-28 |
河北大学 |
一种含有噻唑(嗪)烷酮环的类核苷衍生物及其制备方法和其在药物制剂中的应用
|
WO2012135405A1
(fr)
|
2011-03-31 |
2012-10-04 |
Pharmion Llc |
Synthèse de la 5-azacytidine
|
EP2750768B1
(fr)
|
2011-08-30 |
2018-10-03 |
Astex Pharmaceuticals, Inc. |
Formulations de dérivés de decitabine
|
SG10201602044WA
(en)
|
2011-09-16 |
2016-04-28 |
Gilead Pharmassett Llc |
Methods For Treating HCV
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
CN104114568B
(zh)
|
2011-12-22 |
2017-09-01 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
AU2012358804B2
(en)
|
2011-12-22 |
2018-04-19 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
NZ631601A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9012427B2
(en)
|
2012-03-22 |
2015-04-21 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
PT2861611T
(pt)
|
2012-05-25 |
2016-10-11 |
Janssen Sciences Ireland Uc |
Nucleósidos de espirooxetano de uracilo
|
DK2935303T3
(da)
|
2012-12-21 |
2021-05-03 |
Janssen Biopharma Inc |
4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
|
EA029081B9
(ru)
|
2013-01-31 |
2018-09-28 |
Джилид Фармассет Ллс |
Комбинированный состав двух противовирусных соединений
|
JP2016522172A
(ja)
|
2013-04-12 |
2016-07-28 |
アキリオン ファーマシューティカルズ,インコーポレーテッド |
Hcvを治療するのに有用な重水素化されたヌクレオシドプロドラッグ
|
SI3650014T1
(sl)
|
2013-08-27 |
2022-01-31 |
Gilead Pharmasset Llc |
Formulacija kombinacije dveh protivirusnih spojin
|
US9862743B2
(en)
|
2013-10-11 |
2018-01-09 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
JP6670244B2
(ja)
|
2014-01-07 |
2020-03-18 |
バビタ アグラワル |
免疫調節組成物及びその使用法
|
US10449210B2
(en)
|
2014-02-13 |
2019-10-22 |
Ligand Pharmaceuticals Inc. |
Prodrug compounds and their uses
|
AU2015270090A1
(en)
|
2014-06-06 |
2016-12-22 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
|
EP3164136A4
(fr)
|
2014-07-02 |
2018-04-04 |
Ligand Pharmaceuticals, Inc. |
Composés de promédicaments et leurs utilisations
|
WO2016156570A1
(fr)
|
2015-04-02 |
2016-10-06 |
Ablynx N.V. |
Polypeptides cxcr4-cd-4 bispécifiques à activité anti-vih puissante
|
RU2723590C2
(ru)
|
2015-07-02 |
2020-06-16 |
Оцука Фармасьютикал Ко., Лтд. |
Лиофилизированные фармацевтические композиции
|
LU92821B1
(en)
|
2015-09-09 |
2017-03-20 |
Mologen Ag |
Combination comprising immunostimulatory oligonucleotides
|
GB2542425A
(en)
|
2015-09-21 |
2017-03-22 |
Mologen Ag |
Means for the treatment of HIV
|
WO2017218580A1
(fr)
|
2016-06-14 |
2017-12-21 |
Rejuvenation Therapeutics Corporation |
Procédés synthétiques pour la préparation de nicotinamide riboside et de composés apparentés
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
RU2624018C2
(ru)
*
|
2016-09-26 |
2017-06-30 |
Федеральное государственное бюджетное учреждение науки Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН (ИБХ РАН) |
Амид 5-(тетрагидрофуран-2-ил)-1,2,4-триазол-3-карбоновой кислоты, обладающий противовирусной активностью, и способ его получения
|
EP3661522A2
(fr)
|
2017-08-03 |
2020-06-10 |
Otsuka Pharmaceutical Co., Ltd. |
Composé médicamenteux et ses procédés de purification
|
CA3087932A1
(fr)
|
2018-01-09 |
2019-07-18 |
Ligand Pharmaceuticals, Inc. |
Composes acetal et leurs utilisations therapeutiques
|
CN113382994A
(zh)
*
|
2019-02-01 |
2021-09-10 |
詹森生物制药有限公司 |
抗病毒核苷及其衍生物
|
JOP20220130A1
(ar)
|
2019-12-06 |
2023-01-30 |
Vertex Pharma |
مجموعات تترا هيدروفيوران بها استبدال في صورة عوامل تعديل لقنوات الصوديوم
|
US11827627B2
(en)
|
2021-06-04 |
2023-11-28 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|
EP4370132A2
(fr)
*
|
2021-07-15 |
2024-05-22 |
Alnylam Pharmaceuticals, Inc. |
Multiplexage ciblant des ligands par chimie clic au niveau du site anomérique de sucres
|